
|
www.senology.org
- Newsletter
"Join the international senologic and oncologic scientific community" |
|
|
|
|
|
Gian
Paolo Andreoletti, MD,
Editor-in-Chief - paolo.andreoletti@senology.it |
|
Subscribe Unsubscribe
Contact
Back Issues www.senology.org / www.senology.it Home Page |
|

Literature Selection
-
Veronesi U et al: "The value of radiotherapy on metastatic
internal mammary nodes in breast cancer. Results on a large
series", Ann Oncol. 2008 May 7. [Epub ahead of print]
-
Yi M et al.: "How many sentinel lymph nodes are enough during
sentinel lymph node dissection for breast cancer?", Cancer. 2008
May 5. [Epub ahead of print]
-
Lipov EG et al.: "Effects of stellate-ganglion block on hot
flushes and night awakenings in survivors of breast cancer: a
pilot study", Lancet Oncol. 2008 May 14. [Epub ahead of print]
-
Van Nes JG et al.: "Preoperative chemotherapy is safe in early
breast cancer, even after 10 years of follow-up; clinical and
translational results from the EORTC trial 10902", Breast Cancer
Res Treat. 2008 May 18. [Epub ahead of print]
-
de Cremoux P et al.. "No evidence of Human papillomavirus DNA
sequences in invasive breast carcinoma", Breast Cancer Res
Treat. 2008 May;109(1):55-58
-
Ma H et al.a. "Low-dose medical radiation exposure and breast
cancer risk in women under age 50 years overall and by estrogen
and progesterone receptor status: results from a case-control
and a case-case comparison", Breast Cancer Res Treat. 2008 May;109(1):77-90
-
Mohr SB et al.: "Relationship between
low ultraviolet B irradiance and higher breast cancer risk in
107 countries", Breast J. 2008 May-Jun;14(3):255-60
-
Dodds L et al.: "Relationship of Time
Since Childbirth and Other Pregnancy Factors to Premenopausal
Breast Cancer Prognosis", Obstet Gynecol. 2008 May;111(5):1167-1173
-
Maruti SS et al.: "A Prospective
Study of Age-Specific Physical Activity and Premenopausal Breast
Cancer", Natl Cancer Inst. 2008 May 13. [Epub ahead of print]
-
Rebora P et al.: "Timing of familial breast cancer in sisters",
J Natl Cancer Inst. 2008 May 21;100(10):721-7
-
Clements A et al.: "Diagnosed with breast cancer while on a
family history screening programme: an exploratory qualitative
study", Eur J Cancer Care 2008 May;17(3):245-52
-
Berg WA et al.: "Combined screening
with ultrasound and mammography vs mammography alone in women at
elevated risk of breast cancer", JAMA. 2008 May 14;299(18):2151-63
-
Ailello Bowles EJ et al.: "Accuracy of short-interval follow-up
mammograms by patient and radiologist characteristics", AJR Am J
Roentgenol. 2008 May;190(5):1200-8
-
Mameri CS et al.: "Impact of breast MRI on surgical treatment,
axillary approach, and systemic therapy for breast cancer",
Breast J. 2008 May-Jun;14(3):236-44
-
Warner F et al.: "Systematic review:
using magnetic resonance imaging to screen women at high risk
for breast cancer", Ann Intern Med. 2008 May 6;148(9):671-9
-
Pestalozzi BC et al.: "Distinct Clinical and Prognostic Features
of Infiltrating Lobular Carcinoma of the Breast: Combined
Results of 15 International Breast Cancer Study Group Clinical
Trials", J Clin Oncol. 2008 May 5. [Epub ahead of print]
Editorial
-
"Annual MRI is the
screening test of choice for all women over 30 with BRCA
mutations" - Ellen Warner,
Toronto-Sunnybrook Regional Cancer Center, Toronto, Ontario,
Canada
"Multiple
prospective studies have shown than MRI is much more sensitive
than mammography for screening women with BRCA mutations.
However, since MRI is much more expensive than mammography and
has a 2 - to 3-fold higher rate of false positive results,
finding a subgroup whom mammography alone might be adequate
would be highly desirable. Unfortunately, this study showed
that even in women with low breast density, measured either
qualitatively or quantitatively, mammography detected only 37%
to 43% of invasive breast cancers, compared to a 90% detection
rate for MRI. Furthermore, mammography missed 80% of the cases
of DCIS detected by MRI regardless of breast density. There are
several possible explanations for these findings. Since tumours
grow more quickly in women with BRCA mutations than in women
with non-BRCA cancers, and grow more quickly in younger than in
older women, calcification of the malignant ducts - an important
mammographic feature of malignancy -may not have had time to
occur. Also, BRCA1-related tumours tend to be fleshier with
less fibrous tissue than other breast cancers, which might
decrease mammographic visibility. Finally, even in women with
generally fatty breasts, there may be scattered areas of higher
breast density where tumours would be obscured. Although
digital mammography was not used in this study, it would not be
expected to be superior to film-screen mammography for fatty
breasts. Tomosynthesis, a 3-dimensional mammographic technique
under development, might hold promise for screening high-risk
women, particularly if a contrast agent sensitive to
angiogenesis is used, as is currently routine with MRI. For now,
annual MRI (added to mammography) is the screening test of
choice for all women over 30 with BRCA mutations or a very
strong family history of breast cancer" (Comment on paper:
Bigenwald RZ et al.: "Is Mammography Adequate for Screening
Women with Inherited BRCA Mutations and Low Breast Density?",
Cancer Epidemiol Biomarkers Prev. 2008;17(3):706-11)
Press Releases
Healthcare Companies News
Calendar of Events
- 10th Milan Breast Cancer
Conference, 18-20 Jun, 2008, Milan, Italy
- Era
of Hope, Department of Defense Breast Cancer Conference, 25-28
Jun, 2008, Baltimore, MD. USA
-
Breast
Cancer in Young Women Symposium, 3 July 2008, Lugano,
Switzerland - During the ECLU 2008 Conference
-
Seventh International Congress on the Future of Breast Cancer,
23-26 Jul, Koloa, Hi, USA

Literature Selection
-
Patel P et al.: "Incidence of Types of Cancer among HIV-Infected
Persons Compared with the General Population in the United
States, 1992-2003", Ann Intern Med. 2008 May 20;148(10):728-736
-
Meyer MS et al.: "A review of the
relationship between tooth loss, periodontal disease, and
cancer", Cancer Causes Control. 2008 May 14. [Epub ahead of
print]
-
Guo JH et al.: "Self-expandable esophageal stent loaded with
125I seeds: initial experience in patients with advanced
esophageal cancer", Radiology. 2008 May;247(2):574-81
-
Calderwood AH et al.: "Association between colorectal cancer and
urologic cancers", Arch Intern Med. 2008 May 12;168(9):1003-9
-
Cuzick J et al.: "Long-term follow-up
of cervical abnormalities among women screened by HPV testing
and cytology-Results from the Hammersmith study", Int J Cancer.
2008 May 15;122(10):2294-300
-
Maris JM et al.: "Chromosome 6p22 Locus Associated with
Clinically Aggressive Neuroblastoma", N Engl J Med. 2008 May 7.
[Epub ahead of print]
-
Hays LE et al.: "Cigarette smoke
induces genetic instability in airway epithelial cells by
suppressing FANCD2 expression", Br J Cancer. 2008 May 20;98(10):1653-1661
-
Thomas J et al.: "Methylnaltrexone
for opioid-induced constipation in advanced illness", N Engl J
Med 2008 May 29;358:2332-2343
Editorial
Press Releases
-
"When to wait and when to treat? New program will search for
biomarkers in men with prostate cancer to help find an answer"
- Fred Hutchinson Cancer Research Center, Seattle, WA,
USA - www.fhcrc.org -
"Drug Fends
Off Kidney Cancer Progression" -
Memorial Sloan-Kettering Cancer Center, New York, USA -
www.mskcc.org -
"Gene Therapy Increases Survival for End-Stage Head and Neck
Cancer" -
The University of Texas,
M. D. Anderson Cancer Center, Houston, TX, USA
-
www.mdanderson.org -
"Celebrex Shows Benefit in First-of-Its-Kind Lung Cancer
Chemoprevention Trial" -
The University of Texas,
M. D. Anderson Cancer Center, Houston, TX, USA
- www.mdanderson.org -
"Drug Therapy to Bolster Immune System Cells Found Effective
Toward Childhood Cancer" -
The University of Texas,
M. D. Anderson Cancer Center, Houston, TX, USA
-
www.mdanderson.org
 Literature Selection
|
Educational Grants -
Sincere appreciation is extended to the following companies for
their generous support of this activity:
- Roche
- AstraZeneca
If this e-mail has reached you in
error, simply click on the following link and unsubscribe
yourself: Unsubscribe
Contact info - For
advertising information please contact: A&B@senology.it . For other enquiries, problems or
suggestions please contact: staff@senology.it
© A&B Edizioni
Medico-Scientifiche - Milan, Italy. Fax:
+39.035.7171000 | |